DYAX CORP DYAX (NASDAQ) $ 2.97 Change: -0.26 -8.75% | Volume: 260,940
Sponsored by Click here!

DYAX CORP - Fundamental Profile

Company Information

Ticker Symbol: DYAX
Exchange: NASD
Contact Info: 300 Technology Square Cambridge MA 02139 617 225-2500
CEO/President: Henry E. Blair
Industry: Medical - Biomedical / Standard Industry Code: 8731
Description: Dyax Corp is a biopharmaceutical company that has developed and patented a method that is used to identify a broad range of compounds with potential for the treatment and diagnosis of diseases. The company is also using this method to identify compounds that could be used in purifying andmanufacturing biopharmaceuticals and other chemicals. The company\'s phage display technology to rapidly and cost-effectively determine the potential medical uses of newly discovered proteins and genes and subsequently discover biopharmaceutical product candidates.

Share Information

Shares Outstanding: 60,650 (000) Market Value: 200,130 ($000)
Percentage of Inst.Shareholders: 64.29% Number of Inst.Shareholders: 9.45%
Last Quarter Sales: 5.49 ($Mil.) Last Quarter Net Income: -26.64 ($Mil.)
Last Quarter EPS: -0.29 P/E Ratio: 0
Most Recent Earnings: -0.36 on 04/25/02 Earnings Per Share: -1.24
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN +5.10 55.47
GILEAD SCIENCES -8.10 44.45
CELGENE CP -16.20 55.97
BIOGEN IDEC INC -30.20 44.26
GENENTECH INC +4.70 80.36